ReviewCNS drugs2026

Rozanolixizumab: A Review in AChR or MuSK Autoantibody-Positive Generalised Myasthenia Gravis.

Aisling McGuigan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.